HR-positive/ HER-negative Breast Cancer

View All

Human Epidermal Receptor 2 (HER2)/ HR2 positive negative Breast Cancer
New Therapeutic advances that have shifted the Breast cancer market scenario

HR-positive/HER2-negative breast cancer treatment landscape focuses on the complexity of the specific cancer type and the treatment differ according to the biomarker status. The trend suggests a greater bend towards personalized medicine based upon patient biomarkers and physiologic characteristics In our last a...

Find More

HR-positive/ HER-negative Breast Cancer
HR-positive/ HER2-negative Breast Cancer Market Insights: Upcoming Therapies and Market Analysis

Breast cancer is a serious and most common problem in developed as well as developing countries.About 1 in 8 U.S. women summing up to 12% are at the risk of developing invasive breast cancer over the course of her lifetime. And if we talk about the present scenario, there are over 3 million women in the United Stat...

Find More